Skip to main content
OpenTrials

Clinical trial condition

Carcinoma of Unknown Primary

Explore clinical trials studying Carcinoma of Unknown Primary. Study availability and eligibility vary by location and protocol.

22 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma of Unknown Primary trial results

Completed

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

NCT00066781

Conditions
Carcinoma of Unknown Primary, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • Mercy Cancer Center at Mercy Medical Center - North Iowa Mason City, Iowa, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Cancer Resource Center - Lincoln Lincoln, Nebraska, United States
  • CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States
View Trial Details
Completed

High-dose ICE With Amifostine

NCT00003657

Conditions
AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +80 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

NCT00873119

Conditions
Carcinoma of Unknown Primary, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
  • Baton Rouge Medical Center Baton Rouge, Louisiana, United States
  • Center for Cancers and Blood Disorders Bethesda, Maryland, United States
View all 23 locations
View Trial Details

Related conditions